SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-03-000019
Filing Date
2003-05-05
Accepted
2003-05-05 16:27:39
Documents
4
Period of Report
2003-03-31

Document Format Files

Seq Description Document Type Size
1 03/31/03 10Q ligand030310q.htm 10-Q 305977
3 EXHIBIT 10.256 ex10-256.txt EX-10 137403
4 EXHIBIT 99.1 - CEO CERTIFICATION ex99-1.txt EX-99 1423
5 EXHIBIT 99.2 - CFO CERTIFICATION ex99-2.txt EX-99 1407
  Complete submission text file 0000886163-03-000019.txt   448078
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20720 | Film No.: 03682373
SIC: 2834 Pharmaceutical Preparations